Do you have surfactant related residuals in your product or process?
Do you have a current or potential surfactant problem that we might help you with? Fortunately, it is possible to sensitively monitor for surfactants using LC-ESI-TofMS. We are interested in learning about your surfactant application or problem. Surfactants are everywhere! They are a profoundly useful group of chemicals due to their amphiphilicity and resulting surface activity. There are […]
Fingerprinting for Equivalence in Biomedical Device Testing
InVision Biomedical is launching a new service for our biomedical and chemical industry customers – mass spectrometry based fingerprinting of materials for equivalence assessment. Our state-of-the-art UPLC-UV-QTof Mass Spectrometer XevoR G2-S (Waters) and ProgenesisR QI software package (Nonlinear Dynamics) have been rigorously evaluated by our scientists and found to be well-suited to provide detailed and timely chemical fingerprint […]
Marie Dvorak Christ Presentation – AAPS Southern California – February 2016
Marie Dvorak Christ, PhD, Presentation AAPS Southern California Symposium 2016 The Southern California Pharmaceutical Discussion Group (SCPDG) of AAPS announces: Exploiting High Resolution Accurate Mass QTof MSMS for the Identification of Unknown Analytes in Biomedical Device Leachates and Extracts. Presented by Marie Dvorak Christ, Ph.D. InVision Biomedical Group, Inc. When: Thursday, Feb. 11, 2016 Where: Chapman […]
Extractables & Leachables Small Molecule Impurity ID – Current Approaches and Opportunities
Analytical scientists across industries are often tasked with identification of small molecule impurities in extractables and leachables (E&L) studies of materials used in biomedical devices, contacts and closures (C&C), labels and packaging. Impurity ID is also a key activity throughout the drug development process. Successful identification of an impurity facilitates its thorough toxicological risk assessment, […]
Alignment of Emerging Biomedical R&D Challenges with Tof-HRMS Capability and Versatility
The Biomedical device sector is undergoing rapid expansion and its qualitative and quantitative analytical needs are expanding in unison with this growth. The causes behind this increase are many. One major factor is the availability of venture capital for biomedical devices which has been driven by the “rapid development” timeline of devices which deliver both […]
Custom vs Contract Research Organization – Which C in CRO are YOU looking for?
Contract Research Organizations (CROs) around the country and around the world serve the pre-clinical and clinical phase development of pharmaceuticals and biomedical devices. Most CROs continuously add capabilities to support large and multisite studies, and, in the current outsourcing climate, have attracted substantial venture capital and grown rapidly. Among other services, CROs provide long term, […]
